Stealth BioTherapeutics
Brian Saxton is Vice President, Quality Assurance at Stealth BioTherapeutics. Brian has 30 years of regulated industry experience in medical device and pharmaceuticals including operations, project and functional line management, quality systems, and drug product commercialization. Prior to joining Stealth he served as Senior Director, Quality Assurance at Tesaro managing the QA responsibilities for commercialization of both US- and EU-based drug products. Brian has also been responsible for QA-related commercialization activities with previous companies including Sepracor/Sunovion and Acusphere. In addition to these positions within operating companies, Brian has also served as a consultant to various local pharmaceutical companies. Brian holds a BS in Chemical Engineering from Manhattan College, and an MBA from Boston University.
Stealth BioTherapeutics
1 followers
Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.